Bond.az White LogoBond.az Black Logo

#desmoid-tumor

Latest news and interesting information about desmoid-tumor.

Today / 12:32
|
339

Immunome presents phase 3 trial results for desmoid tumor drug

Immunome announces phase 3 results for varegacestat in desmoid tumors: 84% reduction in progression risk, 56% objective response rate.

0
...